Cannabis Makes Headway in Mainstream Pharma

Cannabis Makes Headway in Mainstream Pharma

Cannabis Makes Headway in Mainstream Pharma

The medical sector of the cannabis industry continues to explode behind constant research and innovative studies for identifying viable cancer treatments and other therapies for different ailments.

Massachusetts Doctors Reluctant to Recommend Medical Marijuana

Massachusetts Doctors Reluctant to Recommend Medical Marijuana

In Massachusetts, very few doctors are making medical marijuana recommendations for patients. According to Boston Globe, 13 doctors have issued medical marijuana recommendations for approximately three quarters of the 31,818 patients in the state.

Report: Minnesota's Medical Cannabis Program Benefitting Patients

Report: Minnesota’s Medical Cannabis Program Benefitting Patients

On June 6, 2016, the Minnesota Department of Health issued a report on survey results collected from patients in the state’s medical cannabis program, revealing that a majority of patients have benefited substantially from using legal medical cannabis.

US researchers call for re-evaluation of microbial testing of Cannabis

US Researchers Call for Re-evaluation of Microbial Testing of Cannabis

A new US study suggests that some of the medicinal benefits of dispensary grade Cannabis could be compromised because the flowers host potentially harmful yeasts and toxic molds, which cannot be detected by industry standard culturing techniques.


Illinois Advisory Board Recommends Expanding Qualifying Conditions

On May 2, 2016, the Illinois Medical Cannabis Advisory Board met to review a request to expand the state’s number of qualifying conditions. According to the Associated Press, the board voted to recommend diabetes and panic disorder as qualifying conditions.

Epidiolex in Utah

Epidiolex in Utah: Decrease in Seizure Frequency and Severity

In September 2014, The University of Utah’s Division of Pediatric Neurology and Primary Children’s Medical Center started the first of three clinical trials on the efficacy of Epidiolex, a nonpsychoactive cannabidiol-based drug from GW Pharmaceuticals (NASDAQ: GWPH).


DEA Approves Study of Smoked Marijuana For Treatment of PTSD

The U.S. Drug Enforcement Agency has given the green light to a clinical study of smoked marijuana’s effectiveness for treating Post Traumatic Stress Disorder in veterans, according to the Multidisciplinary Association for Psychedelic Studies. Seventy-six U.S. veterans will participate in the study.


More and More Doctors Want to Make Marijuana Legal

A group of more than 50 physicians, including a former surgeon general and faculty members at some of the nation’s leading medical schools, has formed the first national organization of doctors to call on states and the federal government to legalize and regulate the use of marijuana in the interest of public health.


Maryland Physicians Registering for State’s Medical Cannabis Program

On March 21, 2016, the Natalie M. LaPrade Maryland Medical Cannabis Commission posted a message from Richard Proctor, the state program’s interim executive director, announcing that 112 physicians have registered to issue written certifications to medical cannabis patients.


Study Finds Medical Marijuana Treatment Reduces Use of Opioids

On March 22, 2016, the University of Michigan announced that a recent study conducted by the U-M School of Public Health and Medical School found that patients who treated chronic pain with medical marijuana had a 64 percent reduction in their use of prescription opioids.

Kindman Disputes CDA's Pesticide Advisory

Kindman Disputes Colorado MED Pesticide Advisory

On March 17, 2016, the Colorado Marijuana Enforcement Division issued a public health and safety advisory regarding potentially unsafe pesticide residues on retail cannabis plant material and products produced from cannabis cultivated by MGI Inc., dba Kindman.


Scientists Develop Method to Accurately Measure Cannabinoids in Edibles

On March 15, 2016, the American Chemical Society announced that scientists have developed a new technique to more accurately measure cannabinoids in cannabis-infused edibles, including gummy bears, brownies and cookies, as well as certain topical lotions. “Producers of cannabis edibles complain that if they send off their product to three different labs for analysis, they get three different


Life After Legalization: Stephen Goldner Leads the Way to FDA

When FDA barriers change, regulations deal fortune to some and hardship to others. On March 4, 2016, at the California Cannabis Business Expo in San Francisco, Stephen Goldner, Senior Forensic Toxicologist at Quantum 9, a cannabis consulting and technology firm, addressed the U.S. Food and Drug Administration’s role in regulating the cannabis industry in life after legalization.

MMJ_dispensary real estate

How ‘Medical’ are Medical Marijuana Programs?

According to a new study released on March 7, more than 1 million people participate in medical marijuana programs in the United States. The new study, conducted at Columbia University Medical Center, New York, found that “while 14 of the nation’s 24 medical marijuana programs were essentially non-medical in practice, they enrolled more than 99


New Study: Cannabis Usage Risks Reduced

In the past cannabis has been the scapegoat of mental health professionals. Much research indicates that use of the plant is responsible for a myriad of mental health problems. However, new research seems to point in a different direction. “Our findings suggest caution in the implementation of policies related to legalization of cannabis for recreational


Mountain High Suckers Issues Major Product Recall

On Dec. 30, 2015, the city of Denver announced that Mountain High Suckers, a Denver-based manufacturer of marijuana-infused products, voluntarily recalled almost 100,000 units after product samples tested positive for potentially unsafe levels of pesticide residues.

UVM Cannabis Course

UVM Department of Pharmacology Teaching Science of Cannabis

On Nov. 17, 2015, the University of Vermont’s College of Medicine launched its course registration for the spring 2016 semester, which included a course titled “Medical Cannabis, Pharm-372.”

Page 1 of 3123